ArticleCurrent microbiology2026
Wavelength-Dependent Reduction of Newcastle Disease Virus Infectivity by Femtosecond Laser Irradiation: An In Ovo Proof-of-Concept Study.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Newcastle disease virus (NDV) causes substantial losses in poultry, and nonchemical approaches for reducing viral infectivity warrant investigation. Ultrafast femtosecond (fs) lasers offer a novel, non-thermal, and photosensitizer-free approach to pathogen inactivation. The primary aim of this study was to evaluate the wavelength-dependent efficacy of femtosecond laser irradiation (370-420 nm) in inactivating NDV, establishing a proof-of-concept for non-chemical viral attenuation using embryonated chicken eggs (ECEs) as a biological model. NDV suspensions were irradiated with 100 fs laser pulses at 370, 385, 400, and 420 nm for 60 min. The treated virus samples (100 µl) were inoculated into specific-pathogen-free (SPF) embryonated chicken eggs at dilutions of 10⁵, 10⁷ and 10⁹ and the viability of the embryo was monitored. Viral infectivity was assessed by embryo mortality and hemagglutination (HA) assays over 168 h. Exposure to 370 nm laser light resulted in > 99.99% reduction in viral infectivity and an estimated ≥ 4-log shift in the infectivity endpoint compared with the control, but complete inactivation was not observed. HA assays showed no protection at 385 and 400 nm on embryo death, but there was partial protection at 420 nm. Temperature monitoring did not show any thermal effects, indicating a non-thermal inactivation mechanism. This study demonstrates the strong antiviral potential of 370 nm femtosecond lasers against NDV; nevertheless, these findings justify further optimization of irradiation dose and independent confirmation by at least three serial passages. Viral antigen integrity, immunogenicity, and protective efficacy must be evaluated separately before any vaccine application.
Indexed as
Identifiers
42920003What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.